PloS one · 2025
Predicting the future risk and outcomes of severe heart failure and coronary artery disease with machine learning in the UK Biobank Cohort.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Taha Karim, Ross Heather J, Peikari Mohammad, Mueller Brigitte, Fan Chun-Po S, Crowdy Edgar, Moayedi Yas, Billia Filio, Manlhiot Cedric
Аннотация
BACKGROUND: In order to seriously impact the global burden of heart failure (HF) and coronary artery disease (CAD), identifying at-risk individuals as early as possible is vital. Risk calculator tools in wide clinical use today are informed by traditional statistical methods that have historically yielded only modest prediction accuracy.
METHODS: This study uses machine learning algorithms to generate predictions models for the development and progression of severe HF and CAD. Participants (~485,000 followed in the UK Biobank over 7 years) were stratified by cardiac status at the time of enrollment (asymptomatic, high-risk and affected); separate prediction models were built for each stratum. Participants were split between a training set (80%) and holdout dataset (20%), all performance metrics are reported for the holdout dataset.
RESULTS: Out of 6 machine learning algorithms screened, artificial neural networks (ANN) most successfully predicted future disease across the various strata (area under the curve: 0.77-0.86 for 10/12 models), results were very consistent between methodologies. Models trained using ANN showed excellent calibration in all strata and across the entire spectrum of risk (0.4-1.2% average observed/predicted difference across 10 deciles of risk). Key predictive features included age, frailty, adiposity, history of hypertension and diabetes, tobacco use and family history of heart disease and were consistent between models for HF and CAD.
CONCLUSIONS: When deployed as a patient-facing application, the prediction models presented here will be able to provide both user-specific predictions and simulate the effect of changes in lifestyle and of prophylaxis interventions, thus resulting in an individualized patient counselling and management tool.
METHODS: This study uses machine learning algorithms to generate predictions models for the development and progression of severe HF and CAD. Participants (~485,000 followed in the UK Biobank over 7 years) were stratified by cardiac status at the time of enrollment (asymptomatic, high-risk and affected); separate prediction models were built for each stratum. Participants were split between a training set (80%) and holdout dataset (20%), all performance metrics are reported for the holdout dataset.
RESULTS: Out of 6 machine learning algorithms screened, artificial neural networks (ANN) most successfully predicted future disease across the various strata (area under the curve: 0.77-0.86 for 10/12 models), results were very consistent between methodologies. Models trained using ANN showed excellent calibration in all strata and across the entire spectrum of risk (0.4-1.2% average observed/predicted difference across 10 deciles of risk). Key predictive features included age, frailty, adiposity, history of hypertension and diabetes, tobacco use and family history of heart disease and were consistent between models for HF and CAD.
CONCLUSIONS: When deployed as a patient-facing application, the prediction models presented here will be able to provide both user-specific predictions and simulate the effect of changes in lifestyle and of prophylaxis interventions, thus resulting in an individualized patient counselling and management tool.